FDA warned Barsotti Juice that its organic carrot juice safety plan does not control Clostridium botulinum.
What happened
FDA inspected Barsotti's juice processing facility in Camino, CA on November 20, November 21 and December 1, 2023. FDA found serious violations of the juice Hazard Analysis and Critical Control Point (HACCP) and current good manufacturing practice rules, including pasteurization limits that were insufficient to inactivate Clostridium botulinum spores and missing critical control points for refrigeration labeling and finished-product storage. Barsotti responded on December 15, 2023, with a justification, a challenge study and a revised plan, but FDA found the response and study inadequate.
What FDA found
The HACCP plan's pasteurization limit did not reliably achieve the required 5-log reduction (a 100,000-fold reduction) of the most resistant pathogen, including Clostridium botulinum spores, for the product's shelf life.
21 CFR 120.24(a)The HACCP plan did not list critical control points for every identified hazard reasonably likely to occur, specifically refrigeration labeling and finished-product refrigerated storage to control Clostridium botulinum growth and toxin formation.
21 CFR 120.8(b)(2)
What FDA wants
FDA asks Barsotti to confirm the February 21, 2024 regulatory meeting or request an alternate date within five business days, and to provide documentation of corrective actions five business days before the call. FDA also asks for a written response to the compliance branch.
Who should pay attention
- juice processors making low-acid refrigerated juices
- retailers and distributors selling refrigerated organic juices
- brands relying on supplier HACCP plans for pathogen control
This is a summary. Read the original letter on fda.gov.